PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

45,809 stories, page 661 of 764

Advanced search
🇿🇦Researchsu.ac.zaTier 3 · Secondary coverage

Prof Hafizah Chenia listens in on microbes to improve global health

Stellenbosch UniversityOriginal source
🇯🇵Industrysumitomo-pharma.comTier 1 · Company source

Matters Concerning Controlling Shareholders, Etc.

Sumitomo PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[Bio USA] Korea Exchange courts global biotech IPOs at Bio USA

The Korea HeraldOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Comment: Pharma’s demand for innovation is powering biotech’s recovery

Healthcare TodayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Haisco and Nuvectis sign licensing deal for two drugs

MSNOriginal source
🌍discoverynews.google.comTier 2 · Trade media

AL-S Pharma Presents AP-101 Phase 2 Data Supporting Misfolded SOD1 as a Therapeutic Target in ALS at ENCALS 2026

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Patent cliffs aren’t the only driver of biotech M&A boom

Financial TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US FDA declines to approve Achieve Life Sciences' smoking-cessation drug

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CalciMedica Receives FDA Clearance to Resume Auxora Clinical Trial for Acute Kidney Injury After Safety Review

MinichartOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

𝐒𝐀𝐅𝐄 𝐅𝐎𝐎𝐃 𝐒𝐓𝐀𝐑𝐓𝐒 𝐖𝐈𝐓𝐇 𝐀𝐖𝐀𝐑𝐄𝐍𝐄𝐒𝐒: 𝐅𝐃𝐀 𝐂𝐄𝐋𝐄𝐁𝐑𝐀𝐓𝐄𝐒 𝐖𝐎𝐑𝐋𝐃 𝐅𝐎𝐎𝐃 𝐒𝐀𝐅𝐄𝐓𝐘 𝐃𝐀𝐘 𝟐𝟎𝟐𝟔

fda.gov.phOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Abu Dhabi DoH Partners with Biocom California on Biotech

BioProcess InternationalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[BIO USA 2026] PanGen Biotech eyes Europe as next market for EPO biosimilar

koreabiomed.comOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Sterigenics U.S., LLC; Filing of Food Additive Petition

The Food and Drug Administration (FDA or we) is announcing that we have filed a food additive petiti...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Notice of Closed Meetings

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Government Owned Inventions Available for License: C8166-45 Cell Line

The National Cancer Institute (NCI) seeks licensees for a human T-cell line, C8166-45, transformed b...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Government Owned Inventions Available for License: Compositions and Methods for Producing Dendritic Cell-based Vaccines With Enhanced Efficacy

The National Cancer Institute (NCI) is seeking research co- development partners and/or licensees fo...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Proposed Information Collection Activity; National and State Survey of Child and Adolescent Well-Being (NSSCAW): Site Recruitment and Baseline Data Collection

The Administration for Children and Families (ACF), Department of Health and Human Services, intends...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Notice of Proposed Purchased/Referred Care Delivery Area Redesignation for the Kewa Pueblo

This Notice advises the public that the Indian Health Service (IHS) proposes to expand the geographi...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Order Under Sections 362 and 365 of the Public Health Service Act Continuing the Suspension of the Right To Introduce Certain Persons From Countries Where a Quarantinable Communicable Disease Exists

The Centers for Disease Control and Prevention (CDC), a component of the Department of Health and Hu...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

National Vaccine Injury Compensation Program; List of Petitions Received

HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Amended Notice of Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Extended Phenytoin Sodium

Official structured record identifier: 363cd347-d25e-42b9-9ce7-30642f3cb353.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Bupropion Hydrochloride

Official structured record identifier: 362504fd-2f0a-c097-e063-6394a90ac0fc.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Quetiapine fumarate

Official structured record identifier: 36248b77-277c-7d66-e063-6394a90ae1e8.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: propranolol hydrochloride

Official structured record identifier: 36230aaa-b6e5-4ebb-e063-6294a90ac3b9.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: GUANFACINE

Official structured record identifier: 35d3c996-1755-c017-e063-6294a90abc1f.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Allergy Relief

Official structured record identifier: 35b807b5-2e7a-446b-b378-eb5391ddfd14.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Clonazepam

Official structured record identifier: 30d674f9-f1b3-4c2d-a8e9-3bc8e476f1ec.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Chemstat

Official structured record identifier: 2e361b50-9268-4053-b13c-93af64549848.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ofloxacin

Official structured record identifier: 2d55b26d-9d12-ca29-e063-6294a90ab237.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Warfarin Sodium

Official structured record identifier: 2cbcc99d-9107-4d39-a1e9-e19305de8b5d.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: BACLOFEN

Official structured record identifier: 2517f71f-f452-1f56-e063-6394a90a6ef1.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Walgreens Gentle Laxative

Official structured record identifier: 20c43036-830b-0e1d-e063-6394a90adf5f.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Walgreens Hemorrhoidal

Official structured record identifier: 20c41406-99b2-bc89-e063-6294a90aed73.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Fluoxetine

Official structured record identifier: 20516384-6517-48be-bd6e-718250878a76.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: unspecified product

Official structured record identifier: 1fa4abb6-5363-6cf3-e063-6294a90a012f.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Nicotine

Official structured record identifier: 1d55fe3e-9c41-409f-8b1d-3c02688903e9.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: divalproex sodium

Official structured record identifier: 1d4129ae-0ce8-4a04-9f9d-c770508de8ed.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Stomach Relief regular strength

Official structured record identifier: 1aa386ac-8ffd-4ba4-9b2e-19156d374c48.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: CIBINQO

Official structured record identifier: 16c12a56-4550-414b-ac9d-b785b41fea6b.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Caduet

Official structured record identifier: 164394b3-d7ba-4bbf-b64b-e2dd15735ea8.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Atomoxetine

Official structured record identifier: 10d36b32-0202-4c03-8a1a-cd5d53f231e7.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Doxepin Hydrochloride

Official structured record identifier: 0d981fbd-3605-417b-91d7-799b21c1a9e3.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Aspirin Regular Strength

Official structured record identifier: 0b27c0fd-7ea8-4588-9169-5ad4e8df77ef.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Aspirin

Official structured record identifier: 055d8420-c189-4a9e-acdc-21627935c8eb.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: RISPERIDONE

Official structured record identifier: 03d3b52d-3a7d-4595-84c9-332da6ca9171.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: UV Daily Hydration Tinted

Official structured record identifier: 02e71602-13e1-43b3-9cba-a75e46cccacc.

openFDA Drug LabelsOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Updates on intratumoral therapies in melanoma

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Exploring chemical space based on Transformation to design broad-spectrum 3CL<sup>pro</sup> inhibitors against coronavirus.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Association of diet composition and meal intervals with short-term glycemic control and glycemic variability among type 2 diabetes mellitus patients.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Fixed BMI eligibility criteria for GLP-1 receptor agonist trials and estimated trial-eligible proportions in Asian and non-Asian populations: A cross-sectional analysis.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Quantifying the Financial Return on Investment of Risk-Based Quality Management Implementation in Clinical Development.

Europe PMCOriginal source
🌍Researchdoi.orgTier 1 · Research record

Incidental Electrocardiographic Recognition of Left Anterior Fascicular Block With Delayed Troponin Elevation: A Case Report With Clinical Correlation

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

The multifaceted role of bile acids in breast cancer: pathogenesis, therapeutic potential, and drug delivery

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Clinical practice guideline of PET/CT and PET/MR in lymphoma (2025 edition)

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Global Pharmaceutical Market Evolution: From Blockbuster Drugs to Biologics and Biosimilars – A Comprehensive Review

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Murder most foul: the Belfast judge’s daughter and the Scottish RAF engineer

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Effect of fusidic acid phonophoresis as a complementary therapy in chronic rhinosinusitis: a randomised clinical trial

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

THE INTEGRATION OF NEW TECHNOLOGIES IN DIABETES CARE: A REVIEW OF CLINICAL APPLICATIONS AND OUTCOMES

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Cross-Cultural Adaptation and Psychometric Evaluation of the Arabic Clinical Reasoning Scale Among Nursing Students

CrossrefOriginal source